Critically ill patients with sepsis and severe COVID-19 are commonly characterized by a
dysregulated immune response and an acute kidney injury. Continuous renal replacement …

Abstract Background Coronavirus disease‐19 (COVID‐19) ranges from asymptomatic
infection to severe cases requiring admission to the intensive care unit. Together with …

BACKGROUND Despite various therapies to treat sepsis, it is one of the leading causes of
mortality in the intensive care unit patients globally. Knowledge about the pathophysiology …

Abstract Introduction: Coronavirus disease 2019 (COVID-19) is characterized by
hyperinflammation and coagulopathy. Severe cases often develop respiratory distress …

In late 2019, a novel betacoronavirus, later termed severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), was discovered in patients with an unknown respiratory …

The blood purification therapy demonstrated the tendency in decrease of cytokines and
endotoxin activity in different degree according to the current studies. However, the effect on …

COVID-19 has been affecting the world unprecedentedly and will remain widely prevalent
due to its elusive pathophysiological mechanism and the continuous emergence of new …

BACKGROUND Millions of human beings have suffered in the epidemic of Coronavirus
disease 2019 (COVID-19), but until now the effective treatment methods have been limited …

Abstract Coronavirus disease 2019 (COVID-19) threatened human lives worldwide since
first reported. The current challenge for global intensivists is to establish an effective …

Background Indirect cardiomyocyte damage-related hyperinflammatory response is one of
the key mechanisms in COVID-19-induced fulminant myocarditis. In addition to the clinical …